
Business Jun 28, 2017
Japan's corporate chiefs face more scrutiny over cushy retirement roles
by Kanoko Matsuyama
For decades, boards allowed former executives to linger on as highly paid advisers, without offering shareholders much detail about their roles. Now, there are signs that cushy retirement gigs may no longer be a sure thing. Japan's largest drugmaker, Takeda Pharmaceutical Co., in an unusual ...